HSHiroshi Shimada

Hiroshi Shimada

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hiroshi Shimada has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Kuniya Tanaka

    Yokohama City University Graduate School of Medicine

    6 shared publications
  • Shinji Togo

    Yokohama City University Graduate School of Medicine

    5 shared publications
  • Yoshiro Fujii

    Department of Surgery II Yokohama City University School of Medicine 3‐9 Fukuura, Kanazawa‐ku Yokohama 236‐0004 Japan

    4 shared publications
  • Hideki Masunari

    Department of Surgery II Yokohama City University School of Medicine 3‐9 Fukuura, Kanazawa‐ku Yokohama 236‐0004 Japan

    3 shared publications
  • Itaru Endo

    Department of Surgery II Yokohama City University School of Medicine 3‐9 Fukuura, Kanazawa‐ku Yokohama 236‐0004 Japan

    3 shared publications
  • Chikara Kunisaki

    Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan

    2 shared publications

Latest Publications

  • A Y-shaped vinyl hood that creates pneumoperitoneum in laparoscopic rectal cancer surgery (Y-hood method.): a new technique for laparoscopic low anterior resection

    by Shoichi Fujii, Mitsuyoshi Ota, Shigeru Yamagishi, Chikara Kunisaki, Shunichi Osada, Hirokazu Suwa, Yasushi Ichikawa, Hiroshi Shimada

    Many studies have focused on laparoscopic techniques for the treatment of colon cancer, but such work is more limited for the treatment of rectal cancer, largely because of concerns for safety issues. This report presents an effective method of anal lavage and excision in laparoscopic low anterior resection. The authors developed clamp forceps for intestinal lavage and a Y-shaped vinyl hood that can be operated under pneumoperitoneum for airproof surgery. These devices enabled secure clamping and cleansing of the area and use of automatic suture instruments for open laparotomy through a minilaparotomy wound. The authors called this technique the Y-Hood method and compared its short-term results from May 2005 to October 2008 (n = 28) with those for double-stapling technique surgical cases between September 2000 and October 2008 in which automatic suture instruments were used more than once (n = 107). A multivariate analysis of risk factors for anastomotic leakage also was performed. No difference in background factors such as patient sex, age, and tumor node metastasis (TNM) staging were detected. Anastomotic leakage was found in 12 cases that used multiple stapling for rectal transection (11.2%) and 2 cases that used the Y-Hood (7.1%). The cost for rectectomy was 92,505 yen for multiple stapling and 53,107 yen for the Y-Hood (p < 0.0001). As risk factors for anastomotic leakage, multivariate analysis identified the number of times stapling for rectal transection was performed and the height of the anastomotic region. The Y-Hood method enables operations to be performed within the interior of the pelvis without reducing the number of ports because the instruments can be accessed using minilaparotomy. Because the use of stapling for rectal transection is minimized, this method is effective in avoiding anastomotic leakage and also cost efficient. The Y-Hood method allows for thorough intestinal lavage and safe laparoscopic low anterior resection.


  • Open Access

    Effect of obesity on intraoperative bleeding volume in open gastrectomy with D2 lymph-node dissection for gastric cancer

    by Hirochika Makino, Chikara Kunisaki, Hirotoshi Akiyama, Hidetaka A Ono, Takashi Kosaka, Ryo Takagawa, Yasuhiko Nagano, Syoichi Fujii, Hiroshi Shimada

    To investigate the effect of obesity on open gastrectomy with D2 lymph-node dissection. Between January 2005 and March 2007, 100 patients with preoperatively diagnosed gastric cancer who underwent open gastrectomy with D2 lymph-node dissection were enrolled in this study. Of these, 61 patients underwent open distal gastrectomy (ODG) and 39 patients underwent open total gastrectomy (OTG). Patients were classified as having a high body-mass index (BMI; ≥ 25.0 kg/m2; n = 21) or a normal BMI (2; n = 79). The visceral fat area (VFA) and subcutaneous fat area (SFA) were assessed as identifiers of obesity using FatScan software. Patients were classified as having a high VFA (≥ 100 cm2; n = 34) or a normal VFA (2; n = 66). The relationship between obesity and short-term patient outcomes after open gastrectomy was evaluated. Patients were classified as having high intraoperative blood loss (IBL; ≥ 300 ml; n = 42) or low IBL (n = 58). Univariate and multivariate analyses were used to identify predictive factors for high IBL. Significantly increased IBL was seen in the following: patients with high BMI versus normal BMI; patients with gastric cancer in the upper third of the stomach versus gastric cancer in the middle or lower third of the stomach; patients who underwent OTG versus ODG; patients who underwent splenectomy versus no splenectomy; and patients with high VFA versus low VFA. BMI and VFA were significantly greater in the high IBL group than in the low IBL group. There was no significant difference in morbidity between the high IBL group and the low IBL group. Multivariate analysis revealed that patient age, OTG and high BMI or high VFA independently predicted high IBL. It is necessary to perform operative manipulations with particular care in patients with high BMI or high VFA in order to reduce the IBL during D2 gastrectomy.


  • Treatment for multiple bilobar liver metastases of colorectal cancer

    by Hiroshi Shimada, Kuniya Tanaka, Kenichi Matsuo, Shinji Togo

    Recent advances have extended indications for hepatectomy to include multiple bilobar colorectal liver metastases (CLM). Staging systems based on the biological malignancy of primary and metastatic tumors provide appropriate indications for hepatectomy in CLM. However, suitability for resection in patients with complex and extensive hepatic metastases is controversial. A medline search was performed to identify papers reporting the resection for CLM. Techniques, indication, and results were reviewed. If the anticipated remnant liver volume is small (25–40% of total), suggesting a high risk of postoperative liver failure, portal vein embolization (PVE) is recommended prior to hepatectomy. However, curative resections are not always possible. Specifically in synchronous multiple bilobar CLM, two-stage hepatectomy, comprising bilateral hepatectomy and primary resection with or without PVE, can prevent growth of ipsilateral metastatic nodules in the remnant liver and reduce surgical risk. Several local ablation techniques can complement surgery if hepatic resection alone increases the risk of postoperative liver failure or is not curative. Chemotherapy combined with targeted treatment can suppress recurrence and extend indications for hepatectomy by reducing the size and number of primary irresectable tumors. PVE or staged procedure combining with local ablation or neoadjuvant, downstaging or adjuvant therapies extends indications for hepatectomy to include multiple bilobar CLM. The 5-year survival rate for multiple bilobar CLM treated with alternating hepatectomy and chemotherapy is comparable to the values reported for single and hemilateral CLM.


  • Results of surgical treatment for multiple (=5 nodules) bi-lobar hepatic metastases from colorectal cancer

    by Hiroshi Shimada, Kuniya Tanaka, Hidenobu Masui, Yasuhiko Nagano, Kenichi Matsuo, Miyuki Kijima, Yasushi Ichikawa, Hideyuki Ike, Shigeo Ooki, Shinji Togo

    The surgery for the treatment of multiple (≥5) bi-lobar hepatic metastases from colorectal cancer is controversial. This retrospective study presents our experience in an attempt to develop reasonable treatment guidelines.


  • Hepatic Resection Combined with Portal Vein or Hepatic Artery Reconstruction for Advanced Carcinoma of the Hilar Bile Duct and Gallbladder

    by Hiroshi Shimada, Itaru Endo, Mitsutaka Sugita, Hideki Masunari, Yoshiro Fujii, Kuniya Tanaka, Koichi Misuta, Hitoshi Sekido, Shinji Togo

    Hepatectomy with vascular reconstruction for biliary malignancy remains controversial. This study aimed to clarify the indications for surgery. Patients with advanced hilar bile duct cancer (HBDC) (n = 26) and gallbladder cancer (GBC) involving the hepatoduodenal ligament (n = 13) who underwent hepatectomy were enrolled. They were divided into two groups on the basis of whether vascular reconstruction was performed (HBDC, 10 yes vs. 16 no; GBC, 5 yes vs. 8 no). Portal vein (PV) reconstruction was performed on the right branch in seven patients and on the left branch in two; hepatic artery (HA) reconstruction was done on the right branch in 11 patients and on the left branch in 1. Five patients with HBDC and one with GBC underwent both PV and HA reconstruction. Patency rates were 88.0% and 83.3% for PV and HA reconstructions, respectively. Vascular reconstruction‐related morbidity occurred in one patient with fatal liver failure owing to a portal thrombus and in two patients with multiple liver abscesses caused by arterial obstruction. Microsurgery eliminated reconstruction‐related morbidity. Mortality in vascular reconstruction cases was 13.3% (2/15), and in those without reconstruction it was 8.3% (2/24). Curability rates (R0 and R1+R2) were 50.0% and 56.0% for HBDC and 40.0% and 62.5% for GBC, respectively. The 3‐year survivals of HBDC patients were, respectively, 33% and 42%, and the 5‐year survivals were 18% and 25%, whereas for GBC the 1‐year survivals were 20% and 60% and the 2‐year survivals 0% and 25%. Two patients with vascular involvement who underwent PV with HA reconstruction survived more than 3 years. Hepatectomy with vascular reconstruction for selected HBDC patients offers low surgical risk and increased survival by curable resection, but it is not recommended for advanced GBC.


  • Is parenchyma-preserving hepatectomy a noble option in the surgical treatment for high-risk patients with hilar bile duct cancer?

    by Hiroshi Shimada, Itaru Endo, Mitsutaka Sugita, Hideki Masunari, Yoshiro Fujii, Kuniya Tanaka, Hitoshi Sekido, Shinji Togo

    Background The essential minimum of hepatic segmentectomy combined with caudate lobectomy (parenchyma-preserving hepatectomy) has been recommended particularly for high-risk patients with hilar bile duct cancer to minimize the risk of postoperative liver failure. This quality control study investigated whether parenchyma-preserving hepatectomy is a "noble option" in the surgical treatment of hilar bile duct cancer. Patients and methods A total of 53 patients with hilar bile duct cancer underwent surgical resection. These patients were retrospectively classified into a major hepatectomy group (major Hx, n=30), a parenchyma-preserving hepatectomy group (preserving Hx, n=11), and a hilar bile duct resection group (HBDR, n=12). A preserving Hx consisted of caudate lobectomy, either alone (n=3), or combined with resection of segment 4 (S4, n=4), or S58 (n=3) or S458 (n=1). The preserving Hx was used for high-risk patients in whom tumor tissue was diagnosed to be Bismuth type I and II by preoperative selective percutaneous transhepatic cholangiography. Results The mean numbers of hepatico-jejunostomies were 2.8, 4.8, and 4.6 in the respective groups. Mortality rates including hospital death were 13.3%, 0%, and 0% respectively. Morbidity rates were 46.7%, 54.5%, and 33.3%. The preserving Hx group encountered no liver failure (T.Bil>10 mg/dl, encephalopathy) but acquired hyperbilirubinemia (T.Bil>5 mg/dl), pulmonary insufficiency and other complications at the same frequency as in the major Hx group. The survival rates in the three groups were 35.6%, 52.5%, and 48.6% at 3 years and 25.2%, 14.9%, and 24.3% at 5 years respectively. Curability rates (R0 to R1+2) were 76.7%, 54.5% and 50.0%, respectively. Preserving Hx tended to result in higher frequencies of positive transmural margins (e.g., cancer cells remaining around the right hepatic artery or the portal vein). Conclusions Preserving hepatectomy for high-risk patients should be limited strictly to patients who do not have tumors which are not invading adjacent organs (e.g., T2) nor a segmental duct and are confined longitudinally to the right or the left.


    • 9 May 2002
      • Vol. 49  (44) , 300-5

    Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma.

    by Hiroshi Shimada, Itaru Endo, Yoshiro Fujii, Osamu Kunihiro, Kuniya Tanaka, Koichiro Misuta, Sinji Togo

    Several surgical procedures from hilar bile duct resection to hepatectomy have been adopted for hilar cholangiocarcinoma. However the details of the surgical procedure and the indications for hilar bile duct resection have not been determined. Pathohistological outcome of resected specimens in five patients undergoing extended hilar bile duct resection was reviewed and compared with 12 patients undergoing partial hepatectomy with caudate lobectomy. Extended hilar bile duct resection was used for older patients, cases of choledochal site and less invasive tumor. The mean lengths of the left hepatic duct (21.7 +/- 7.8 mm) and the anterior hepatic duct (18.0 +/- 3.2 mm) in the specimens resected by extended hilar bile duct resection did not differ from those seen in right and left hepatectomy, respectively. Furthermore, extended hilar bile duct resection removed partial caudal hepatic duct. However the length of the posterior hepatic duct removed by extended hilar bile duct resection (14.3 +/- 2.0 mm) was significantly less than that excised in left hepatectomy (19.3 +/- 6.6 mm) (P < 0.05). The histologic positive margin rate of the extended hilar bile duct resection group (40%) was the same as that of the hepatectomy group (50%). Papillary or nodular form tumor tended to have positive ductal margins in both surgical techniques. On the other hand, flat tumor tended to have high positive rates in both ductal and excisional margins even in hepatectomy. Two cases with positive surgical margin died of local recurrences, however another 3 cases with negative surgical margin are alive without recurrences from 8 to 20 months after surgery. The indication of extended hilar bile duct resection for hilar cholangiocarcinoma is limited to cases in which the infiltration is confined to the hepatic bifurcation, such as type I and type II of Bismuth classification with regard to papillary and nodular macroscopic appearance.


  • Appraisal of surgical resection of gallbladder cancer with special reference to lymph node dissection.

    by Hiroshi Shimada, Itaru Endo, Yoshiro Fujii, Noriyuki Kamiya, Hideki Masunari, Osamu Kunihiro, Kuniya Tanaka, Kouichiro Misuta, Shinji Togo